Key Market Drivers: The Growth Factors
The laboratory animal models, and 3D cultures market is experiencing significant growth due to dynamic changes, opportunities, and growing demand in the pharma sector.
The top 4 key growth factors are below:
- Ethical Alternatives to Animal Testing
3D cell cultures are emerging as a promising platform for translational and regenerative medicine. They offer a more complex and biologically relevant model for studying cellular behavior and interactions. As such, 3D cell cultures are expected to gain wider adoption across various scientific research fields. The growing popularity of 3D cell culture products is evident in their increasing applications and prevalence, especially in the early stages of drug development.
Furthermore, the growing emphasis on ethical alternatives to animal testing is accelerating the adoption of 3D cell culture products. Regulatory bodies are actively working to replace, reduce, and refine animal use in research, which has led to increased demand for alternative approaches. Non-animal models that accurately predict human responses to drugs are also expected to fuel the market for alternatives to animal testing.
- Advanced Tumor Modeling: A New Frontier
One of the most exciting applications of 3D cell cultures is in the field of oncology or cancer. Traditional cancer research has struggled to accurately model the tumor microenvironment, a complex system that plays a crucial role in tumor progression and drug resistance. 3D cell cultures, however, are changing that narrative by enabling the creation of tumor spheroids and organoids that closely resemble actual tumors.
- Biobanking and Its Role in Drug Development
Biobanking, the process of collecting and storing biological samples for research, is another area ready for transformation through 3D cell cultures. Traditional biobanks store samples in a static state, often losing critical cellular functions. 3D cultures, however, allow for the preservation of live cells in a dynamic environment, maintaining their viability and functionality over time.
- Increasing Adoption of Organoid Technology
Organoids, three-dimensional cell cultures that mimic organ structure and function, are groundbreaking technology with immense potential for biomedical research. Their ability to replicate organ architecture and physiological processes opens new avenues for disease study, drug discovery, and personalized medicine.
Organoids have grown in popularity over the past decade, finding widespread application in fields such as disease modeling, pathogenesis, drug discovery, personalized medicine, and regenerative medicine.
Top 5 Companies Shaping the 3D Cell Culture Market
- Thermo Fisher Scientific Inc. (1956) - Thermo Fisher Scientific develops instruments, reagents, software, and services for the life sciences industry. The company has four business segments: life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services.
- Corning Inc. (1851) - Corning's Life Sciences segment, a leading developer, manufacturer, and global supplier of scientific laboratory products, collaborating with researchers to enhance efficiencies, reduce costs, and expedite drug discovery processes. Corning operates 124 facilities in 15 countries to produce its products, with 49,800 employees worldwide.
- genOway (1999) - genOway is a multinational biotechnology company that offers preclinical models and solutions for maximum predictability to biopharmaceutical companies and government agencies. It focuses on immuno-oncology and immunotherapy, offering custom-designed models with high predictability. It is a leading life sciences company based in Lyon, France, has over 140 employees from 17 countries. It serves clients across 28 countries and five continents, including leading companies and academic institutions, highlighting its global reach.
- Charles River Laboratories (1947) - Charles River Laboratories is an early-stage CRO founded in 1947. It has undergone several changes in business structure. Charles River Laboratories International Inc. was incorporated in 1994. The company offers extensive services from basic research to discovery, safety, and efficacy to clinical support and manufacturing. These services are provided to customers globally, including leading pharmaceutical and biotechnology companies, agrochemical companies, government, and academic organizations.
The company operates in three reportable segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support. The company provides more than 100 facilities in over 20 countries.
- Bio-Techne (1976) - It is one of the pioneers of cutting-edge instruments for clinical diagnostics, therapeutic manufacturing, and life science research. The company develops, produces, and markets life science instruments, reagents, and services to the global research, diagnostics, and bioprocessing markets. It commercializes essential parts of scientific investigations into biological processes and molecular diagnostics, exposing nature, diagnosis, etiology, and diseases.
The company operates in two segments: Protein Sciences and Diagnostics and Genomics. As of June 2023, the company had over 3,050 employees with around 500,000 products in the global market.
Future Outlook: Revolutionizing Medical Research
The future of 3D cultures and organoids is bright, with the potential to revolutionize medical research and healthcare delivery. As these technologies continue to mature, they will enable more precise and personalized approaches to disease management, improving patient outcomes and quality of life.
As the biopharmaceutical industry continues to embrace these innovations, 3D cultures and organoids will play an increasingly central role in shaping the future of medicine. By offering ethical, accurate, and efficient research methodologies, they are ready to drive a new era of scientific discovery and medical breakthroughs.
Learn More and Take Action:
Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.
Contact us today to find out more.
